BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6657650)

  • 1. Dopaminergic control of sympathetic activity and blood pressure in haemodialysis patients.
    Sturani A; Degli Esposti E; De March A; Santoro A; Fuschini G; Zuccalà A; Chiarini C; Flamigni C; Zucchelli P
    Proc Eur Dial Transplant Assoc; 1983; 20():156-60. PubMed ID: 6657650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients.
    Degli Esposti E; Sturani A; Santoro A; Zuccalà A; Chiarini C; Zucchelli P
    Clin Sci (Lond); 1985 Jul; 69(1):51-6. PubMed ID: 3905210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic and dopaminergic regulation of circulating beta-endorphin-like immunoreactivity in hypertension.
    Alföldi A; Simkó K; Fekete MI; Farsang C
    Acta Physiol Hung; 1991; 78(1):99-106. PubMed ID: 1763654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing haemodynamic stability due to differing sympathetic response: comparison of ultrafiltration, haemodialysis and haemofiltration.
    Baldamus CA; Ernst W; Fassbinder W; Koch KM
    Proc Eur Dial Transplant Assoc; 1980; 17():205-12. PubMed ID: 7243770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.
    Zilch O; Vos PF; Oey PL; Cramer MJ; Ligtenberg G; Koomans HA; Blankestijn PJ
    J Hypertens; 2007 Jun; 25(6):1285-9. PubMed ID: 17563543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased number of alpha-adrenergic receptors in platelets of patients on maintenance haemodialysis.
    Brodde OE; Daul A; Graben N
    Proc Eur Dial Transplant Assoc; 1983; 19():270-4. PubMed ID: 6308599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability.
    Pelosi G; Emdin M; Carpeggiani C; Morales MA; Piacenti M; Dattolo P; Cerrai T; Macerata A; L'abbate A; Maggiore Q
    Clin Sci (Lond); 1999 Jan; 96(1):23-31. PubMed ID: 9857103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of sympathetic nerve activity and arterial endothelial function in pathogenesis of hypertension in patients with obstructive sleep apnea-hypopnea syndrome].
    Zhang J; Chen BY; Han JY; Cao J; Guo MN; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):437-41. PubMed ID: 17673017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of pentolinium on sympathetic activity in hypertensives and normotensive controls.
    Murphy MB; Brown MJ; Causon RC; Dollery CT
    Int J Clin Pharmacol Res; 1983; 3(4):227-32. PubMed ID: 6678820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.
    Moretti JL; Burke SL; Evans RG; Lambert GW; Head GA
    J Hypertens; 2009 Sep; 27(9):1838-48. PubMed ID: 19512943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hyperinsulinaemia and hypertension: the role of the sympathetic nervous system.
    Moreau P; Lamarche L; Laflamme AK; Calderone A; Yamaguchi N; de Champlain J
    J Hypertens; 1995 Mar; 13(3):333-40. PubMed ID: 7622855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
    Al-Hesayen A; Parker JD
    Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excessive prolactinemic response to sulpiride in patients with mild essential hypertension. Index of diminished hypothalamic dopaminergic activity].
    Paladini G; Sponza E; Geatti O; Di Chiara F; Bertolutti T
    Minerva Med; 1980 Sep; 71(31):2229-35. PubMed ID: 6999383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced activity of sympathetic renal nerves in hypertensive patients with unilateral renal ischemia--its relationship to plasma renin activity in renal venous blood.
    Wiecek A; Heidland A; Gilge U; Kokot F; Kuczera M; Kiersztejn M
    Clin Nephrol; 1993 Dec; 40(6):326-31. PubMed ID: 8299240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.